ERBB2 and neoplasm: Through decreasing the production of HER2 protein, metformin induced a similar effects as AG825 on suppressing HER2 phosphorylation, thus restraining the activity of HIF-1α-VEGF signaling axis and suppressing tumor angiogenesis in vivo.